A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-08-14

AUTHORS

H-H Sherry Chow, Linda L Garland, Brandy M Heckman-Stoddard, Chiu-Hsieh Hsu, Valerie D Butler, Catherine A Cordova, Wade M Chew, Terri L Cornelison

ABSTRACT

BACKGROUND: Breast cancer risk is partially determined by several hormone-related factors. Preclinical and clinical studies suggested that resveratrol may modulate these hormonal factors. METHODS: We conducted a pilot study in postmenopausal women with high body mass index (BMI ≥ 25 kg/m2) to determine the clinical effect of resveratrol on systemic sex steroid hormones. Forty subjects initiated the resveratrol intervention (1 gm daily for 12 weeks) with six withdrawn early due to adverse events (AEs). Thirty-four subjects completed the intervention. RESULTS: Resveratrol intervention did not result in significant changes in serum concentrations of estradiol, estrone, and testosterone but led to an average of 10% increase in the concentrations of sex steroid hormone binding globulin (SHBG). Resveratrol intervention resulted in an average of 73% increase in urinary 2-hydroxyestrone (2-OHE1) levels leading to a favorable change in urinary 2-OHE1/16α-OHE1 ratio. One participant had asymptomatic Grade 4 elevation of liver enzymes at the end of study intervention. Two subjects had Grade 3 skin rashes. The remaining adverse events were Grade 1 or 2 events. The most common adverse events were diarrhea and increased total cholesterol, reported in 30% and 27.5% of the subjects, respectively. CONCLUSION: We conclude that among overweight and obese postmenopausal women, daily 1 gm dose of resveratrol has favorable effects on estrogen metabolism and SHBG. Further placebo-controlled studies are needed to confirm our findings on these hormone-related breast cancer risk factors and the attribution of the adverse effects observed in the study population. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01370889. More... »

PAGES

223

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12967-014-0223-0

DOI

http://dx.doi.org/10.1186/s12967-014-0223-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1031841082

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25115686


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Mass Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Demography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Estrogens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gonadal Steroid Hormones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pilot Projects", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postmenopause", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Resveratrol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stilbenes", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA", 
          "id": "http://www.grid.ac/institutes/grid.134563.6", 
          "name": [
            "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chow", 
        "givenName": "H-H Sherry", 
        "id": "sg:person.012102466317.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012102466317.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA", 
          "id": "http://www.grid.ac/institutes/grid.134563.6", 
          "name": [
            "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garland", 
        "givenName": "Linda L", 
        "id": "sg:person.01322145005.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322145005.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Heckman-Stoddard", 
        "givenName": "Brandy M", 
        "id": "sg:person.01220375527.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220375527.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA", 
          "id": "http://www.grid.ac/institutes/grid.134563.6", 
          "name": [
            "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hsu", 
        "givenName": "Chiu-Hsieh", 
        "id": "sg:person.015672377047.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015672377047.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA", 
          "id": "http://www.grid.ac/institutes/grid.134563.6", 
          "name": [
            "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Butler", 
        "givenName": "Valerie D", 
        "id": "sg:person.0607247550.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607247550.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA", 
          "id": "http://www.grid.ac/institutes/grid.134563.6", 
          "name": [
            "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cordova", 
        "givenName": "Catherine A", 
        "id": "sg:person.01001177373.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001177373.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA", 
          "id": "http://www.grid.ac/institutes/grid.134563.6", 
          "name": [
            "University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chew", 
        "givenName": "Wade M", 
        "id": "sg:person.01365336174.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365336174.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cornelison", 
        "givenName": "Terri L", 
        "id": "sg:person.0710245566.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710245566.73"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/b:caco.0000024256.48104.50", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008786126", 
          "https://doi.org/10.1023/b:caco.0000024256.48104.50"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-08-14", 
    "datePublishedReg": "2014-08-14", 
    "description": "BACKGROUND: Breast cancer risk is partially determined by several hormone-related factors. Preclinical and clinical studies suggested that resveratrol may modulate these hormonal factors.\nMETHODS: We conducted a pilot study in postmenopausal women with high body mass index (BMI\u2009\u2265\u200925\u00a0kg/m2) to determine the clinical effect of resveratrol on systemic sex steroid hormones. Forty subjects initiated the resveratrol intervention (1 gm daily for 12\u00a0weeks) with six withdrawn early due to adverse events (AEs). Thirty-four subjects completed the intervention.\nRESULTS: Resveratrol intervention did not result in significant changes in serum concentrations of estradiol, estrone, and testosterone but led to an average of 10% increase in the concentrations of sex steroid hormone binding globulin (SHBG). Resveratrol intervention resulted in an average of 73% increase in urinary 2-hydroxyestrone (2-OHE1) levels leading to a favorable change in urinary 2-OHE1/16\u03b1-OHE1 ratio. One participant had asymptomatic Grade 4 elevation of liver enzymes at the end of study intervention. Two subjects had Grade 3 skin rashes. The remaining adverse events were Grade 1 or 2 events. The most common adverse events were diarrhea and increased total cholesterol, reported in 30% and 27.5% of the subjects, respectively.\nCONCLUSION: We conclude that among overweight and obese postmenopausal women, daily 1 gm dose of resveratrol has favorable effects on estrogen metabolism and SHBG. Further placebo-controlled studies are needed to confirm our findings on these hormone-related breast cancer risk factors and the attribution of the adverse effects observed in the study population.\nTRIAL REGISTRATION: ClinicalTrials.gov: NCT01370889.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12967-014-0223-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2693409", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438836", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2427047", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1032886", 
        "issn": [
          "1479-5876"
        ], 
        "name": "Journal of Translational Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "sex steroid hormones", 
      "higher body mass index", 
      "body mass index", 
      "adverse events", 
      "resveratrol intervention", 
      "postmenopausal women", 
      "steroid hormones", 
      "mass index", 
      "clinical studies", 
      "grade 3 skin rash", 
      "Further placebo-controlled studies", 
      "breast cancer risk factors", 
      "grade 4 elevations", 
      "common adverse events", 
      "obese postmenopausal women", 
      "placebo-controlled study", 
      "cancer risk factors", 
      "breast cancer risk", 
      "hormone-related factors", 
      "pilot clinical study", 
      "skin rash", 
      "total cholesterol", 
      "gm dose", 
      "clinical effects", 
      "serum concentrations", 
      "estrogen metabolism", 
      "OHE1 ratio", 
      "risk factors", 
      "liver enzymes", 
      "study population", 
      "study intervention", 
      "cancer risk", 
      "hormonal factors", 
      "grade 1", 
      "pilot study", 
      "favorable changes", 
      "adverse effects", 
      "favorable effect", 
      "hormone", 
      "resveratrol", 
      "intervention", 
      "women", 
      "subjects", 
      "significant changes", 
      "rash", 
      "overweight", 
      "SHBG", 
      "diarrhea", 
      "estradiol", 
      "testosterone", 
      "factors", 
      "study", 
      "cholesterol", 
      "dose", 
      "globulin", 
      "index", 
      "events", 
      "effect", 
      "risk", 
      "estrone", 
      "metabolism", 
      "elevation", 
      "increase", 
      "participants", 
      "changes", 
      "concentration", 
      "population", 
      "findings", 
      "average", 
      "levels", 
      "enzyme", 
      "ratio", 
      "end", 
      "attribution", 
      "systemic sex steroid hormones", 
      "asymptomatic Grade 4 elevation", 
      "hormone-related breast cancer risk factors", 
      "NCT01370889"
    ], 
    "name": "A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones", 
    "pagination": "223", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1031841082"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12967-014-0223-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25115686"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12967-014-0223-0", 
      "https://app.dimensions.ai/details/publication/pub.1031841082"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_648.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12967-014-0223-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0223-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0223-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0223-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0223-0'


 

This table displays all metadata directly associated to this object as RDF triples.

253 TRIPLES      22 PREDICATES      118 URIs      108 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12967-014-0223-0 schema:about N1bc8c59f54944e8fbd8c11583224a495
2 N3517a6fcffb34cb086e67656c5da3c5b
3 N42e89038c1f8443b9340c0d339d64342
4 N5df438d9dbcb497cb81b3d33ad25ceae
5 N83397067534140cfa790959c3508d0ac
6 N84dcd97c13084aefbbb26f48c77e0bbf
7 N8ab55f54fa8e4e01abc977193fad4d04
8 N90a8b0f557d040a4a57bbd00e0795ccf
9 N9153926adbed4d06af3778e58f5f3811
10 N94f67b00b3d6454a9dba21777d80e983
11 N9cb10980f91b4cc8acd73117bbe1b1a1
12 Ne1fa7441f66d49e193f9878e37486c04
13 anzsrc-for:11
14 anzsrc-for:1103
15 anzsrc-for:1117
16 schema:author N71c8b182de2645a59fe5a2ca763b6119
17 schema:citation sg:pub.10.1023/b:caco.0000024256.48104.50
18 schema:datePublished 2014-08-14
19 schema:datePublishedReg 2014-08-14
20 schema:description BACKGROUND: Breast cancer risk is partially determined by several hormone-related factors. Preclinical and clinical studies suggested that resveratrol may modulate these hormonal factors. METHODS: We conducted a pilot study in postmenopausal women with high body mass index (BMI ≥ 25 kg/m2) to determine the clinical effect of resveratrol on systemic sex steroid hormones. Forty subjects initiated the resveratrol intervention (1 gm daily for 12 weeks) with six withdrawn early due to adverse events (AEs). Thirty-four subjects completed the intervention. RESULTS: Resveratrol intervention did not result in significant changes in serum concentrations of estradiol, estrone, and testosterone but led to an average of 10% increase in the concentrations of sex steroid hormone binding globulin (SHBG). Resveratrol intervention resulted in an average of 73% increase in urinary 2-hydroxyestrone (2-OHE1) levels leading to a favorable change in urinary 2-OHE1/16α-OHE1 ratio. One participant had asymptomatic Grade 4 elevation of liver enzymes at the end of study intervention. Two subjects had Grade 3 skin rashes. The remaining adverse events were Grade 1 or 2 events. The most common adverse events were diarrhea and increased total cholesterol, reported in 30% and 27.5% of the subjects, respectively. CONCLUSION: We conclude that among overweight and obese postmenopausal women, daily 1 gm dose of resveratrol has favorable effects on estrogen metabolism and SHBG. Further placebo-controlled studies are needed to confirm our findings on these hormone-related breast cancer risk factors and the attribution of the adverse effects observed in the study population. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01370889.
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree true
24 schema:isPartOf Nb04f0d5f64dc4dc0bc24d351debada4a
25 Nc0187ed228664ddc89b14d24fd11ba0e
26 sg:journal.1032886
27 schema:keywords Further placebo-controlled studies
28 NCT01370889
29 OHE1 ratio
30 SHBG
31 adverse effects
32 adverse events
33 asymptomatic Grade 4 elevation
34 attribution
35 average
36 body mass index
37 breast cancer risk
38 breast cancer risk factors
39 cancer risk
40 cancer risk factors
41 changes
42 cholesterol
43 clinical effects
44 clinical studies
45 common adverse events
46 concentration
47 diarrhea
48 dose
49 effect
50 elevation
51 end
52 enzyme
53 estradiol
54 estrogen metabolism
55 estrone
56 events
57 factors
58 favorable changes
59 favorable effect
60 findings
61 globulin
62 gm dose
63 grade 1
64 grade 3 skin rash
65 grade 4 elevations
66 higher body mass index
67 hormonal factors
68 hormone
69 hormone-related breast cancer risk factors
70 hormone-related factors
71 increase
72 index
73 intervention
74 levels
75 liver enzymes
76 mass index
77 metabolism
78 obese postmenopausal women
79 overweight
80 participants
81 pilot clinical study
82 pilot study
83 placebo-controlled study
84 population
85 postmenopausal women
86 rash
87 ratio
88 resveratrol
89 resveratrol intervention
90 risk
91 risk factors
92 serum concentrations
93 sex steroid hormones
94 significant changes
95 skin rash
96 steroid hormones
97 study
98 study intervention
99 study population
100 subjects
101 systemic sex steroid hormones
102 testosterone
103 total cholesterol
104 women
105 schema:name A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones
106 schema:pagination 223
107 schema:productId N493955627a1544c4b4458e245b7d8ef2
108 Na17d004f0e4b401491963b06ca6bf00d
109 Neb88044cce094f7b9f2e54d3b3f8fbdb
110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031841082
111 https://doi.org/10.1186/s12967-014-0223-0
112 schema:sdDatePublished 2022-01-01T18:35
113 schema:sdLicense https://scigraph.springernature.com/explorer/license/
114 schema:sdPublisher N0701fa12b7d74af895f6f2826a987aae
115 schema:url https://doi.org/10.1186/s12967-014-0223-0
116 sgo:license sg:explorer/license/
117 sgo:sdDataset articles
118 rdf:type schema:ScholarlyArticle
119 N0701fa12b7d74af895f6f2826a987aae schema:name Springer Nature - SN SciGraph project
120 rdf:type schema:Organization
121 N1bc8c59f54944e8fbd8c11583224a495 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Stilbenes
123 rdf:type schema:DefinedTerm
124 N1d32f8cd46b948d588126b255f9675f9 rdf:first sg:person.01220375527.70
125 rdf:rest N66ecdcdcfda44bb68c41bd34f21282eb
126 N1f838f4509d648f786cf827c18c8d430 rdf:first sg:person.01001177373.23
127 rdf:rest N856299e0f1ee44a7a48ae9561d4b7cdc
128 N3517a6fcffb34cb086e67656c5da3c5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Resveratrol
130 rdf:type schema:DefinedTerm
131 N4062d75375694049b30fd8ca7581a41f rdf:first sg:person.0607247550.68
132 rdf:rest N1f838f4509d648f786cf827c18c8d430
133 N42e89038c1f8443b9340c0d339d64342 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Demography
135 rdf:type schema:DefinedTerm
136 N493955627a1544c4b4458e245b7d8ef2 schema:name pubmed_id
137 schema:value 25115686
138 rdf:type schema:PropertyValue
139 N5d1ea3e21c49472b8e75c855794f70f0 rdf:first sg:person.01322145005.35
140 rdf:rest N1d32f8cd46b948d588126b255f9675f9
141 N5df438d9dbcb497cb81b3d33ad25ceae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Adult
143 rdf:type schema:DefinedTerm
144 N66ecdcdcfda44bb68c41bd34f21282eb rdf:first sg:person.015672377047.92
145 rdf:rest N4062d75375694049b30fd8ca7581a41f
146 N71c8b182de2645a59fe5a2ca763b6119 rdf:first sg:person.012102466317.96
147 rdf:rest N5d1ea3e21c49472b8e75c855794f70f0
148 N83397067534140cfa790959c3508d0ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Middle Aged
150 rdf:type schema:DefinedTerm
151 N84dcd97c13084aefbbb26f48c77e0bbf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Pilot Projects
153 rdf:type schema:DefinedTerm
154 N856299e0f1ee44a7a48ae9561d4b7cdc rdf:first sg:person.01365336174.46
155 rdf:rest Nca2458770a814abcbe3cef3f23e1e1ea
156 N8ab55f54fa8e4e01abc977193fad4d04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Estrogens
158 rdf:type schema:DefinedTerm
159 N90a8b0f557d040a4a57bbd00e0795ccf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Humans
161 rdf:type schema:DefinedTerm
162 N9153926adbed4d06af3778e58f5f3811 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Postmenopause
164 rdf:type schema:DefinedTerm
165 N94f67b00b3d6454a9dba21777d80e983 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Female
167 rdf:type schema:DefinedTerm
168 N9cb10980f91b4cc8acd73117bbe1b1a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Gonadal Steroid Hormones
170 rdf:type schema:DefinedTerm
171 Na17d004f0e4b401491963b06ca6bf00d schema:name dimensions_id
172 schema:value pub.1031841082
173 rdf:type schema:PropertyValue
174 Nb04f0d5f64dc4dc0bc24d351debada4a schema:volumeNumber 12
175 rdf:type schema:PublicationVolume
176 Nc0187ed228664ddc89b14d24fd11ba0e schema:issueNumber 1
177 rdf:type schema:PublicationIssue
178 Nca2458770a814abcbe3cef3f23e1e1ea rdf:first sg:person.0710245566.73
179 rdf:rest rdf:nil
180 Ne1fa7441f66d49e193f9878e37486c04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Body Mass Index
182 rdf:type schema:DefinedTerm
183 Neb88044cce094f7b9f2e54d3b3f8fbdb schema:name doi
184 schema:value 10.1186/s12967-014-0223-0
185 rdf:type schema:PropertyValue
186 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
187 schema:name Medical and Health Sciences
188 rdf:type schema:DefinedTerm
189 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
190 schema:name Clinical Sciences
191 rdf:type schema:DefinedTerm
192 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
193 schema:name Public Health and Health Services
194 rdf:type schema:DefinedTerm
195 sg:grant.2427047 http://pending.schema.org/fundedItem sg:pub.10.1186/s12967-014-0223-0
196 rdf:type schema:MonetaryGrant
197 sg:grant.2438836 http://pending.schema.org/fundedItem sg:pub.10.1186/s12967-014-0223-0
198 rdf:type schema:MonetaryGrant
199 sg:grant.2693409 http://pending.schema.org/fundedItem sg:pub.10.1186/s12967-014-0223-0
200 rdf:type schema:MonetaryGrant
201 sg:journal.1032886 schema:issn 1479-5876
202 schema:name Journal of Translational Medicine
203 schema:publisher Springer Nature
204 rdf:type schema:Periodical
205 sg:person.01001177373.23 schema:affiliation grid-institutes:grid.134563.6
206 schema:familyName Cordova
207 schema:givenName Catherine A
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001177373.23
209 rdf:type schema:Person
210 sg:person.012102466317.96 schema:affiliation grid-institutes:grid.134563.6
211 schema:familyName Chow
212 schema:givenName H-H Sherry
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012102466317.96
214 rdf:type schema:Person
215 sg:person.01220375527.70 schema:affiliation grid-institutes:grid.48336.3a
216 schema:familyName Heckman-Stoddard
217 schema:givenName Brandy M
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220375527.70
219 rdf:type schema:Person
220 sg:person.01322145005.35 schema:affiliation grid-institutes:grid.134563.6
221 schema:familyName Garland
222 schema:givenName Linda L
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322145005.35
224 rdf:type schema:Person
225 sg:person.01365336174.46 schema:affiliation grid-institutes:grid.134563.6
226 schema:familyName Chew
227 schema:givenName Wade M
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365336174.46
229 rdf:type schema:Person
230 sg:person.015672377047.92 schema:affiliation grid-institutes:grid.134563.6
231 schema:familyName Hsu
232 schema:givenName Chiu-Hsieh
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015672377047.92
234 rdf:type schema:Person
235 sg:person.0607247550.68 schema:affiliation grid-institutes:grid.134563.6
236 schema:familyName Butler
237 schema:givenName Valerie D
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607247550.68
239 rdf:type schema:Person
240 sg:person.0710245566.73 schema:affiliation grid-institutes:grid.48336.3a
241 schema:familyName Cornelison
242 schema:givenName Terri L
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710245566.73
244 rdf:type schema:Person
245 sg:pub.10.1023/b:caco.0000024256.48104.50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008786126
246 https://doi.org/10.1023/b:caco.0000024256.48104.50
247 rdf:type schema:CreativeWork
248 grid-institutes:grid.134563.6 schema:alternateName University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA
249 schema:name University of Arizona Cancer Center, 1515 N Campbell Ave, 85724 Tucson, AZ USA
250 rdf:type schema:Organization
251 grid-institutes:grid.48336.3a schema:alternateName Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland
252 schema:name Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland
253 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...